re: Clov possible short squeeze

I’ve been in CLOV for a bit. I think it’s a good company that has gotten a bad rep from Hindenburg. Normally Hindenburg is pretty on target, but this one stands out as crap. The allegations were based around a DOJ inquiry into the company related to its Medicare/Medicaid division. Supposedly the company should have disclosed that and didn’t. The company and Chamath insist they didn’t need to disclose it and that it wasn’t anything abnormal. Now the govt just signed them to new exclusive deals in 10 states for Medicare and Medicaid, which means they didn’t do anything fraudulent that could hurt their contracts. IMO there’s no real threat and a ton of positive upside available now. I’ve added more recently